Qiagen NV | QIA - Pre Tax Profit


Qiagen NV reported $157.9M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
argenx SE USD 426M 22.71M Mar/2026
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Moderna USD -1.33B 535M Mar/2026
Organon & Co USD 183M 30M Jun/2026
Qiagen NV USD 157.9M 72.08M Jun/2026
Revvity USD 187.24M 137.25M Jun/2026
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -247.3M 95.7M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026